Inventor · disambiguated record
Carola Ries
Also filed as: RIES CAROLA
21 granted patents·14 pending applications·184 citations·filing 2010–2023
96Inventor score
Top patents by PatentIndex Score
35 records- 0195US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0294US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0394US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0494US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0593US9624302B2Nucleic acids encoding antibodies against human CSF-1RHOFFMANN LA ROCHE·Filed 2015·Granted Apr 18, 2017·11 cites·11 claims
- 0693US9617342B2Nucleic acids encoding antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 11, 2017·11 cites·9 claims
- 0793US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 0892US9221910B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Dec 29, 2015·20 cites·12 claims
- 0992US9192667B2Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonistHOFFMANN LA ROCHE·Filed 2014·Granted Nov 24, 2015·22 cites·13 claims
- 1091US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 1191US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 1291US9169323B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Oct 27, 2015·13 cites·15 claims
- 1390US9988458B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jun 5, 2018·6 cites·14 claims
- 1489US10030073B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·5 cites·23 claims
- 1589US8999327B2Antibodies against human CSF-1R and uses thereofDIMOUDIS NIKOLAOS·Filed 2010·Granted Apr 7, 2015·16 cites·10 claims
- 1688US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 1784US10336830B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·15 claims
- 1883US10023643B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Jul 17, 2018·5 cites·7 claims
- 1971US2019300614A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2070US2015073129A1Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1HOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2169US11498968B2Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatmentHOFFMANN LA ROCHE·Filed 2019·Granted Nov 15, 2022·2 cites·12 claims
- 2268US11512133B2Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1HOFFMANN LA ROCHE·Filed 2020·Granted Nov 29, 2022·0 cites·14 claims
- 2364US2015080556A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2462US2018346581A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2561US2019185572A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2661US2025197491A1Compositions and methods for modulation of macrophage activityMACOMICS LTD·Filed 2023·Application pending·0 cites
- 2758US2017051065A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2855US2017247459A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2953US2017275368A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 3052US2014079706A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3149US2016220669A1Combination therapy of antibodies against human csf-1r and tlr9 agonistHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 3248US2018273628A1Generation of human macrophages in immunodeficient non-human hostsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3340US2018222985A1Antibodies against human csf-1r for use in inducing lymphocytosis in lymphomas or leukemiasHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3439US2020268762A17-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancerHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3537US11542335B2Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)HOFFMANN LA ROCHE·Filed 2019·Granted Jan 3, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Carola Ries files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →